Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents

OBJECTIVES: A novel ultrasound contrast agent (UCA) VEGFR2-targeting iron-doped silica (SiO(2)) hollow nanoparticles (VEGFR2-PEG-HSNs-Fe NPs) was prepared and applied in microwave ablation for breast cancer to investigate its value in the evaluation of effectiveness after tumor ablation. METHODS: VE...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyu, Xia, Shujun, Ji, Ri, Zhan, Weiwei, Zhou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329532/
https://www.ncbi.nlm.nih.gov/pubmed/34354946
http://dx.doi.org/10.3389/fonc.2021.690152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329532/
https://www.ncbi.nlm.nih.gov/pubmed/34354946
http://dx.doi.org/10.3389/fonc.2021.690152

Ejemplares similares